Oncolytics Biotech Inc
T2N 1X7 Calgary, Canada
Oncolytics Biotech Inc Company Information
Informazioni Generali
Oncolytics Biotech is conducting clinical studies using REOLYSIN®, its proprietary formulation of the human reovirus, in some of the most prevalent forms of the disease including lung, colorectal and pancreatic cancers. Oncolytics’ clinical program includes a number of human trials at a variety of stages including a Phase III trial in head and neck cancers. The Company has advanced its product manufacturing and intellectual property initiatives in parallel with its clinical development program to support development of a commercial product.
210, 1167 Kensington Crescent NW Calgary
- Orari di apertura
- Parcheggio
- L'azienda ha un parcheggio.
- Numero di telefono
- +1403-670-7377
- Linki
- Account Social
- Parole chiave
- azienda di biotecnologia
Oncolytics Biotech Inc Reviews & Ratings
How do you rate this company?
Are you the owner of this company? If so, do not lose the opportunity to update your company's profile, add products, offers and higher position in search engines.